Trastuzumab Emtansine

1

Review clinical trials related to Trastuzumab Emtansine. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Trastuzumab Emtansine(T-DM1) After Trastuzumab Deruxtecan(T-DXd) in HER2-Positive Breast Cancer in Korea

Prospective observational study of trastuzumab emtansine immediately after trastuzumab deruxtecan in patients with advanced HER2-positive breast cancer in Korea

Participants needed: 100
Trial details
Age: 19+Biological sex: AllType: ObservationalSponsor: Seoul National University HospitalUpdated: Apr 23, 2026Locations: 1
Eligibility criteria

HER2-positive, advanced (unresectable locally advanced or metastatic) breast can... [+2]

Any systemic treatment, other than T-DM1, for breast cancer after trastuzumab de... [+3]